Cannabis Edibles Consumer Data: 2026 Demographics, Occasions, Dosing, Brand Loyalty & Churn

May 3, 2026 | Gourmet Edibles Market Intelligence

Executive Summary: 42M Americans used edibles past year. 34% are 65+, fastest growing demo. Avg dose 8.2mg, down from 12.4mg 2021. 68% cite sleep/pain/relax vs 22% recreation. Brand loyalty 19% vs 64% alcohol. Churn 48% annually. Microdose 2.5mg = 38% of new trial. This extreme-detail brief covers demographics, occasion mapping, dose titration, purchase drivers, loyalty, churn, and 2026 segmentation strategy.

42M

US Users Past Year

8.2mg

Avg Dose 2026

19%

Brand Loyalty

48%

Annual Churn

1. Demographics: Who Buys Edibles 2026 vs 2021

42M past-year users, 28M past-month, 11M weekly+. Edibles = 32% of total cannabis revenue but 51% of new users start with edibles vs 28% flower. No smoke, precise dose, discreet. Demo shift massive 2021-2026.

Age	2021 Share	2026 Share	Growth	Avg Dose	Top Occasion
21-34	41%	28%	-32%	12.4mg	Social/fun
35-49	33%	31%	-6%	9.1mg	Unwind/stress
50-64	19%	24%	+26%	6.8mg	Sleep/pain
65+	7%	17%	+143%	4.2mg	Sleep/pain

Gender: Female 54% vs 46% 2021. Women = 61% of gummy buyers, 72% of chocolate, 38% of beverage. Men = 68% of high-dose 100mg, 71% of nano shots. Women cite sleep 41%, anxiety 33%, pain 28%. Men cite relax 38%, sleep 29%, fun 31%.

Income: <$50K 31%, $50-100K 42%, $100K+ 27%. Premium $35+ SKUs: 68% bought by $100K+. Value <$15: 71% bought by <$50K. Household income predicts dose: $100K+ avg 10.8mg, <$50K avg 6.1mg.

Geography: CA 22% of users, 18% of revenue due to price compression. NY/NJ/IL 31% of revenue, 19% of users due to limited license pricing. FL medical 14% of users, 21% of revenue. OK 3% users, 1% revenue. Per capita: OK 4.2g THC/yr, CA 3.8g, IL 3.1g, NY 1.9g.

2. Occasions, Dosing & Purchase Drivers 2026

Top 5 Occasions: 1) Sleep 38% of uses, avg 7.4mg, 9pm-11pm, repurchase 72%. 2) Relax/unwind 31%, 6.8mg, 6pm-9pm, repurchase 58%. 3) Pain 27%, 9.2mg, all day, repurchase 81%. 4) Social 18%, 5.1mg, weekends, repurchase 41%. 5) Creativity/focus 9%, 2.8mg, daytime, repurchase 34%. Note: Multi-select, total >100%.

Dose Titration: First-time avg 6.1mg. 22% start 2.5mg, 48% start 5mg, 24% start 10mg, 6% start 20mg+. 90-day users avg 8.2mg. 1yr+ users 11.4mg. Dose creep +0.3mg/month. Microdose 2.5mg = 38% of new SKUs 2025, 41% of trial purchases. 10mg standard = 52% of volume. 100mg = 4% volume, 11% revenue.

Purchase Drivers Ranked: 1) Effect/sleep/pain 68%. 2) Taste 61%. 3) Dose accuracy 54%. 4) Price 52%. 5) Onset time 48%. 6) Brand 19%. 7) Organic/vegan 14%. 8) THC/CBD ratio 12%. 9) Packaging 9%. 10) Made in USA 4%. Taste beats price for 61% if effect correct.

Format	Share Units	Share $	Avg mg	Top Demo	Repurchase
Gummy	68%	61%	8.4mg	All	64%
Chocolate	14%	18%	9.8mg	35+ F	71%
Beverage	7%	9%	5.2mg	21-34	38%
Mint/tab	5%	4%	2.6mg	50+ micro	58%
Baked	4%	5%	12.1mg	Legacy	44%
Capsule	2%	3%	14.2mg	Medical	82%

3. Brand Loyalty, Churn & 2026 Segmentation

Loyalty Crisis: 19% buy same brand 3+ times vs 64% alcohol, 58% supplements. Reasons: 1) Effect inconsistent 42%. 2) Price shopping 38%. 3) Budtender switched 31%. 4) Stock-out 28%. 5) New flavor 22%. Brands with >30% loyalty: Wyld 34%, Wana 31%, Camino 29%. Drivers: Effect consistency ±5% THC, taste, budtender SPIFFs.

Churn Math: 48% annual churn. Avg customer life 2.1 years. LTV $182. CAC $31 DTC, $42 retail via slotting/SPIFF. LTV:CAC 4.4:1 retail, 5.9:1 DTC. Churn triggers: 1) Bad first dose too high 28%. 2) Slow onset 22%. 3) Price increase >15% 19%. 4) Stock-out 17%. 5) Found cheaper 14%. Reduce churn: Start 2.5mg, fast-acting option, consistent inventory, loyalty 10% off.

2026 Segmentation:

1) Canna-Curious 21-34, 18% of users: 2.5-5mg, social, gummy, $15-22, trial. Low loyalty 12%, high churn 61%. Win: Flavor, Instagram, 15min onset.

2) Wellness Mom 35-49, 24%: 5-10mg, sleep/stress, gummy/chocolate, $18-28, repeat. Loyalty 26%, churn 39%. Win: Effect, taste, brand trust, subscribe.

3) Pain/Sleep 50+, 41%: 5-15mg, pain/sleep, gummy/chocolate/capsule, $22-35, highest LTV. Loyalty 31%, churn 33%. Win: Consistency, easy-open, large font, doctor rec.

4) Legacy Enthusiast 21-49, 11%: 20-100mg, recreation, all formats, $25-45, low volume. Loyalty 14%, churn 52%. Win: Potency, terpene, brand story.

5) Medical 35+, 6%: 10-50mg, Rx, capsule/tincture, $35-65, insurance. Loyalty 82%, churn 12%. Win: Doctor channel, COA, consistency.

2026 Winning Formula:

1) Launch: 2.5mg fast-acting + 10mg standard. Covers 78% of doses.

2) Message: Effect > THC. “Sleep” not “10mg.”

3) Price: $19.99 100mg pack. $0.20/mg. 40% margin.

4) Retention: Subscribe 20% off + free ship >$50. Email 2x/week.

5) Churn fix: First order includes dosing card + 2.5mg sample. Cuts bad trip churn 62%.

© 2026 Gourmet Edibles Market Intelligence | For informational purposes. Consumer data: BDSA Q1 2026 n=12,400, Headset, Flowhub, survey data. Not medical advice. Consult physician for dosing. Demographics self-reported.